In recent years, therapy for lung cancer treatment have been developing rapidly, with many new molecular targets in the treatment of lung cancer have been discovered such as EGFR, ROS1, KRAS, ALK, PD-L1... which help to prolong patients' survival time and and improve patient's quality of their life.